Cite

HARVARD Citation

    Lim, S. et al. (2022). Prevalence of Medical Contraindications to Nirmatrelvir/Ritonavir in a Cohort of Hospitalized and Nonhospitalized Patients With COVID-19. Open forum infectious diseases. p. . [Online]. 
  
Back to record